PLAY PODCASTS
Blood cancer specialists say NZ lagging behind with treatments

Blood cancer specialists say NZ lagging behind with treatments

The Health Minister has agreed to meet with a group of blood cancer specialists who wrote an open letter expressing their alarm at Kiwi patients dying unecessarily because Aotearoa is lagging behind with treatments. The dozens of doctors, nurses and clinician reseachers say New Zealand blood cancer patients are being deprived of modern, targetted, funded, go to treatments, that are available globally; including the myeloma drug, Daratumumab. Professor Judith Trotman is the Chair of the Australasian Leukaemia Lymphoma Research Group and an expat Kiwi-Australian haematolgist in Sydney she spoke to Lisa Owen.

Checkpoint · RNZ

March 13, 20269m 4s

Audio is streamed directly from the publisher (flex.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

The Health Minister has agreed to meet with a group of blood cancer specialists who wrote an open letter expressing their alarm at Kiwi patients dying unecessarily because Aotearoa is lagging behind with treatments. The dozens of doctors, nurses and clinician reseachers say New Zealand blood cancer patients are being deprived of modern, targetted, funded, go to treatments, that are available globally; including the myeloma drug, Daratumumab. Professor Judith Trotman is the Chair of the Australasian Leukaemia Lymphoma Research Group and an expat Kiwi-Australian haematolgist in Sydney she spoke to Lisa Owen.

Topics

healthblood cancercancer treatments